Real‐world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B‐cell lymphoma by line of therapy

Documenti analoghi

• Real‐world characteristics and outcomes of patients with multiple myeloma receiving second‐line treatment in England
  di: Sally Moore, et al.
  Pubblicazione: (2024)
• Real‐world outcomes of patients with relapsed/refractory large B‐cell lymphoma receiving second‐line therapy in England
  di: Christopher P. Fox, et al.
  Pubblicazione: (2024)
• Real‐world treatment patterns and outcomes with oral azacitidine maintenance therapy in patients with acute myeloid leukemia
  di: Brian Leber, et al.
  Pubblicazione: (2025)
• Association of race/ethnicity and insurance with survival in patients with diffuse large B‐cell lymphoma in a large real‐world cohort
  di: Yanling Jin, et al.
  Pubblicazione: (2024)
• Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study
  di: Jiyun Lee, et al.
  Pubblicazione: (2024)